TRISALUS LIFE SCIENCES
TriSalus Life Sciences, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The company's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, which collapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.
TRISALUS LIFE SCIENCES
Industry:
Biotechnology Developer Platform Hardware Medical
Founded:
2009-01-01
Address:
Westminster, Colorado, United States
Country:
United States
Website Url:
http://www.trisaluslifesci.com
Total Employee:
11+
Status:
Active
Contact:
3034261223
Email Addresses:
[email protected]
Total Funding:
125.65 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF SSL By Default HSTS IPv6 Microsoft Exchange Online Office 365 Mail Pound Sterling Cloudflare CDN
Similar Organizations
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Geospace Research
Geospace Research develops ultrasound systems for the diagnosis of a variety of medical pathologies.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
OrbiMed
OrbiMed investment in Post-IPO Debt - TriSalus Life Sciences
Partisan Management Group
Partisan Management Group investment in Series D - TriSalus Life Sciences
ORI Capital
ORI Capital investment in Series D - TriSalus Life Sciences
MCG Capital
MCG Capital investment in Series C - TriSalus Life Sciences
High Country Venture
High Country Venture investment in Series C - TriSalus Life Sciences
Tullis Health Investors
Tullis Health Investors investment in Series C - TriSalus Life Sciences
KMG Capital Partners
KMG Capital Partners investment in Series C - TriSalus Life Sciences
Partisan Management Group
Partisan Management Group investment in Series C - TriSalus Life Sciences
High Country Venture
High Country Venture investment in Series B - TriSalus Life Sciences
MCG Capital
MCG Capital investment in Series B - TriSalus Life Sciences
Official Site Inspections
http://www.trisaluslifesci.com Semrush global rank: 8.16 M Semrush visits lastest month: 625
- Host name: 20.142.74.34.bc.googleusercontent.com
- IP address: 34.74.142.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "TriSalus Life Sciences"
About TriSalus Life Sciences®
TriSalus Life Sciences ® was established to develop and commercialize disruptive drug delivery technology for the treatment of liver and pancreatic tumors. Our proprietary Pressure-Enabled …See details»
Clinical Trials - Trisalus
Medical professionals may also email us at [email protected] for more information about study participation. Ongoing Clinical Trials. Locally-Advanced Pancreatic Ductal …See details»
Trisalus Life Sciences - Overview, News & Similar companies
May 19, 2024 Trisalus Life Sciences contact info: Phone number: (888) 321-5212 Website: www.trisaluslifesci.com What does Trisalus Life Sciences do? TriSalus Life Sciences is an …See details»
TriSalus Life Sciences: Contact Details and Business Profile
Trisaluslifesci.com; 1 303408XXXX; View Similar People. Related Companies EVS, LLC. 57 $10m ReleaseTEAM, Inc. 31 $6m Cerapedics Inc. 225 $16m Plato BioPharma, Inc. 10 $5m Lattice …See details»
Trisalus Life Sciences Company Profile | Management and
Www.trisaluslifesci.com Trisalus Life Sciences Profile and History TriSalus Life Sciences is an emerging immuno-oncology company dedicated to developing immunotherapy treatments for …See details»
TriSalus Life Sciences - LinkedIn
TriSalus Life Sciences | 4,636 followers on LinkedIn. An immunotherapy company working to improve the lives of patients living with liver and pancreatic tumors | TriSalus Life Sciences is …See details»
TriSalus Life Sciences Completes Merger with MedTech Acquisition ...
Aug 10, 2023 We are moving forward with the financial resources needed to grow our commercial organization and fund our key milestones through mid-2024. We believe that we …See details»
Trisalus Life Sciences Company Profile -Sales, Contacts, …
Www.trisaluslifesci.com: There are 2 Companies located at 6272 W 91ST AVE, Westminster, CO 80031 Map ... Business Description Trisalus Life Sciences is located in Westminster, …See details»
TriSalus Life Sciences, Inc. (TLSI) - Yahoo Finance
See the company profile for TriSalus Life Sciences, Inc. (TLSI) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Culture - Trisalus
Liver and pancreatic tumors are difficult to treat. TriSalus aims to enable patients with these cancers to realize the promise of immunotherapy through our innovative platform approach. In the lab, the clinic, the office and the field, …See details»
TriSalus Life Sciences - Company Profile - Tracxn
Nov 5, 2024 TriSalus Life Sciences ranks 4th among 98 active competitors. 32 of its competitors are funded while 23 have exited. Overall, TriSalus Life Sciences and its competitors have …See details»
Release Details - investors.trisaluslifesci.com
Feb 10, 2022 To learn more, visit www.trisaluslifesci.com and follow us on Twitter @TriSalusLifeSci and LinkedIn. Media Contact. Samantha Leonardo, 202-220-8910. MPR …See details»
TriSalus Life Sciences Names Chief Business Officer - Tullis Funds
The company created the Pressure-enabled Drug Delivery (PEDD) technology and is committed to developing other applications of the technology for use in other solid tumors and for the …See details»
Careers - Trisalus
Nov 26, 2024 TriSalus never conducts its interview process via messaging apps, freelance sites, or social media platforms (i.e. Google Hangouts, WhatsApp, Signal, etc.). TriSalus team …See details»
TriSalus Life Sciences Opens Its First Research ... - Tullis Funds
Apr 12, 2022 PERIO™-02 (NCT05220722), recently opened for patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. A separate trial for locally advanced …See details»
TriSalus Life Sciences, Inc. (TLSIW) - Yahoo Finance Canada
Find the latest TriSalus Life Sciences, Inc. (TLSIW) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
TriSalus Life Sciences Provides Update on Development of …
Jun 22, 2022 Media: [email protected] Release Summary TriSalus Life Sciences provides an update on research that supports novel immunotherapy platform approach for …See details»
TriSalus Life Sciences Opens Its First Research Laboratory on …
Apr 12, 2022 PERIO™-02 (NCT05220722), recently opened for patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. A separate trial for locally advanced …See details»
TriSalus Life Sciences, Inc. (TLSI) - Stock Analysis
2 days ago Website https://trisaluslifesci.com. Full Company Profile. Financial Performance. In 2023, TriSalus Life Sciences's revenue was $18.51 million, an increase of 49.31% compared …See details»